AS

Akash Sanjay Surana

Active Director Designated Partner DIN 11079509
DIN 11079509 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Akash Sanjay Surana

Data last updated:

Akash Sanjay Surana is a Designated Partner at Bloodtestbuddy Healthcare Llp (since 2025).

DIN 11079509
Primary Designation Designated Partner
First Appointment 28 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Apr 20252025Active

Board colleagues of Akash Sanjay Surana

NameDINCompanyDesignation
Avdut Vijaykumar Kulkarni11079508Bloodtestbuddy Healthcare LlpDesignated Partner
Dhananjay Rajaram Pawar11079507Bloodtestbuddy Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Bloodtestbuddy Healthcare Llp
Premium access

Shareholding and investment profile for Akash Sanjay Surana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Sanjay Surana

Akash Sanjay Surana currently holds 1 directorship: Bloodtestbuddy Healthcare Llp (Designated Partner, since 28 Apr 2025).

Akash Sanjay Surana was first appointed on 28 Apr 2025 as Designated Partner at Bloodtestbuddy Healthcare Llp.

The current boards of Akash Sanjay Surana's companies include Avdut Vijaykumar Kulkarni (Bloodtestbuddy Healthcare Llp), Dhananjay Rajaram Pawar (Bloodtestbuddy Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available